Skip to main content

Table 2 Surgery performed. Placebo (PLA) group and lidocaine (LIDO) group, data as mean ± SD or n (%)

From: Intravenous lidocaine to prevent endothelial dysfunction after major abdominal surgery: a randomized controlled pilot trial

 

PLA (n = 20)

LIDO (n = 20)

Laparotomy

11 (55)

12 (60)

Laparoscopy

4 (20)

5 (25)

Both

5 (25)

3 (15)

Interventions

 Total Mesorectal Excision

3 (15)

2 (10)

 Gastrectomy (total or partial)

2 (10)

3 (15)

 Duodeno-Cephalo-Pancreatectomy

8 (40)

4 (20)

 Abdominoperineal resection

1 (5)

1 (5)

 Surrenalectomy

1 (5)

1 (5)

 Ovarian cancer cytoreductive surgery

2 (10)

1 (5)

 Extensive retroperitoneal lymphadenectomy

0

1 (5)

 Nephrectomy (total or partial)

2 (10)

6 (30)

 Cystectomy

1 (5)

1 (5)

 Duration, skin-to-skin (min)

232 ± 89

228 ± 80